Chantal Belorgey

Dr. Chantal Bélorgey is Head of the HTA division at Haute Autorité de Santé (HAS) - France. Before joining HAS in June 2016, Chantal Bélorgey led the Department of Recommendations, Medicines and Quality of expertise at the French National Cancer Institute (INCa). Previously, she was the counselor of the French Ministry of Health (2012-2014) in charge of Health products and technologies and served for 19 years at the French regulatory National Agency of Health Products (ANSM) where she particularly headed the Division of Medicines in Onco-hematology and the Department of Clinical Trials and Expanded Access Medicines. She has been particularly involved in patient access to drugs along their life cycle - by promoting access through clinical trials as a National expert at the European experts Committee for clinical trials , Chairman of the European Clinical Trials Facilitation Group (CTFG), coordinating National Authorities assessments; - by creating and developing the French ATU system, allowing a secured access to drugs before their marketing authorization; - and now as head of HTA division at HAS.